FDA Inspection 785889 — InvaGen Pharmaceuticals, Inc.

InvaGen Pharmaceuticals, Inc. — FEI 3003950641

The FDA completed an inspection of InvaGen Pharmaceuticals, Inc. on June 14, 2012 in Hauppauge, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 14, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hauppauge, NY (United States)

Citations

IDCFRDescription
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination